Free Trial

Dermata Therapeutics (DRMAW) SEC Filings & 10K Form

$0.02 0.00 (-4.82%)
As of 02:40 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Dermata Therapeutics SEC Filings

DateFilerForm TypeView
07/07/2025
4:25 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2025
8:00 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2025
4:20 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
2:26 PM
ARMISTICE CAPITAL, LLC (Filed by)
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
Form SCHEDULE 13G/A
05/14/2025
8:00 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2025
8:01 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
11:15 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form EFFECT
04/15/2025
7:30 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2025
8:37 PM
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
PROEHL GERALD T (Filed by)
Form SCHEDULE 13D/A
04/03/2025
5:00 PM
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
PROEHL GERALD T (Filed by)
Form SCHEDULE 13D/A
03/28/2025
4:01 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
7:00 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
4:29 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
3:15 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/17/2025
3:17 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:41 PM
ARMISTICE CAPITAL, LLC (Filed by)
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
Form SCHEDULE 13G/A
02/13/2025
5:00 PM
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
PROEHL GERALD T (Filed by)
Form SCHEDULE 13D/A
02/05/2025
11:15 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form EFFECT
02/05/2025
4:30 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 424B3
02/04/2025
3:22 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form D/A
01/30/2025
3:09 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/28/2025
4:25 PM
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SCHEDULE 13G
01/28/2025
4:00 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/23/2025
8:54 PM
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
PROEHL GERALD T (Filed by)
Form SCHEDULE 13D/A
01/23/2025
4:00 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
HALE DAVID F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:02 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
PROEHL GERALD T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:03 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Van Hoose Kyri K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:04 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
FISHER MARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:16 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
7:05 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
5:56 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
WIERENGA WENDELL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:56 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
HALE DAVID F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:56 PM
Bedoya-Toro Munera Maria E (Reporting)
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:57 PM
Bradrick Brittany (Reporting)
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:57 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Nardo Christopher J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:58 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Sandler Andrew Seth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:49 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:50 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Mento Steven J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:50 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
PROEHL GERALD T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:50 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Van Hoose Kyri K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
5:50 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
FISHER MARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Your blueprint for crypto wealth (Ad)

The crypto market is heating up, with massive opportunities ahead for those who know where to look. Join us at the Crypto Community Summit to hear from industry experts as they reveal their top picks and predictions for the second half of 2025. Don’t miss out on these must-know secrets that could position your portfolio for explosive growth

Click here to secure your spot now!
11/13/2024
3:16 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/27/2024
4:00 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
09/24/2024
11:15 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form EFFECT
09/24/2024
3:16 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 424B3
09/19/2024
3:46 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/17/2024
4:25 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:49 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DRMAW) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners